Ocular Therapeutix Announces Successful Completion of Study of Sustained Drug Delivery Moxifloxacin Punctum Plug
October 14, 2010
Ocular Therapeutix, Inc. announced the successful completion of a clinical study of their sustained drug delivery moxifloxacin punctum plug. The study was a single-site, single-armed, single-dose study in which 10 patients received the punctum plug immediately following cataract surgery and were evaluated over a 10-day period.
Primary outcome measures were plug retention and moxifloxacin levels above the minimum concentration to stop growth in various strains of bacterial conjunctivitis.
Click here to read the full press release.
Jump down to form below to submit your own comments